Serena Williams says she has lost weight using GLP-1 medication. The drugs help manage blood sugar and promote weight loss, ...

After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s | ...

Glucagon-like peptide 1 (GLP 1) analogues Market GLP-1 analogues market grows fast with rising diabetes & obesity, driven by innovation, weight loss benefits, and strategic pharma investments.

This study reveals that a low FODMAP diet alleviates IBS symptoms and increases GLP-1 levels, suggesting new avenues for ...

Most people have likely heard about the new weight-loss and diabetes management drugs called Ozempic and Mounjaro, which are also called GLP-1 medications, short for glucagon-like peptide-1 agonists, ...

BehemothLabz's GLP-1 spray is single-function and free from excipients that complicate compatibility, making it suitable for side-by-side analog exploration or receptor-specific pathway studies.

Uncover the truth about GLP-1 weight loss drugs like Ozempic and Mounjaro. Learn how they work, who benefits most, potential risks, and why experts say they can be game-changing tools for fighting ...

This study reveals that a low FODMAP diet alleviates IBS symptoms and increases GLP-1 levels, suggesting new avenues for dietary interventions in gut health.

As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental oral GLP-1 has prompted weight loss up to an average of 27.3 pounds in the first of two pivotal trials, queuing up plans ...

What advantages does GPCR have in the competitive landscape of oral GLP-1 agonists? Structure Therapeutics has several potential advantages in the competitive landscape of oral GLP-1 agonists.